Medicare Enrolled
Dr. Shail Dalal, MD
Hematology & Oncology · Palestine, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dalal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dalal? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dalal
Dr. Shail Dalal is a hematology & oncology in Palestine, TX, with 19 years in practice. Based on federal Medicare data, Dr. Dalal performed 96,172 Medicare services across 3,160 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dalal received a total of $184,926 from 57 pharmaceutical and/or device companies across 474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dalal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 8% volume in TX$ $184,926 industry payments
Medicare Practice Summary
Medicare Utilization ↗96,172
Medicare services
Top 8% in TX for hematology & oncology
3,160
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,062 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 26,520 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) | 20,700 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 14,900 | $43 | $136 |
| Contrast dye for imaging (iodine-based) | 7,895 | $0 | $3 |
| Darbepoetin injection (Aranesp) for anemia | 7,245 | $2 | $20 |
| Denosumab injection (Prolia/Xgeva) | 3,120 | $18 | $66 |
| Dexamethasone injection (steroid) | 3,090 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,760 | $1 | $114 |
| Blood draw (venipuncture) | 1,584 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,215 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 990 | $0 | $24 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 626 | $22 | $157 |
| Office visit, established patient (20-29 min) | 612 | $60 | $250 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 564 | $80 | $1,348 |
| Office visit, established patient (30-39 min) | 448 | $92 | $368 |
| Administration of chemotherapy into vein, 1 hour or less | 434 | $98 | $707 |
| Injection, potassium chloride, per 2 meq | 415 | $0 | $1 |
| Injection, zoledronic acid, 1 mg | 397 | $7 | $431 |
| Comprehensive metabolic blood panel | 367 | $10 | $64 |
| Injection, carboplatin, 50 mg | 319 | $2 | $300 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 303 | $270 | $2,762 |
| Drug injection, under skin or into muscle | 284 | $10 | $96 |
| Microscopic examination for white blood cells with manual cell count | 224 | $4 | $22 |
| Complete blood count (CBC), automated | 224 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 213 | $47 | $313 |
| Administration of additional new drug or substance into vein, 1 hour or less | 168 | $49 | $344 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 161 | $16 | $100 |
| Administration of chemotherapy into vein, each additional hour | 152 | $21 | $161 |
| Red blood count, automated test | 119 | $4 | $23 |
| Injection, diphenhydramine hcl, up to 50 mg | 111 | $1 | $7 |
| Reticulated (young) platelet measurement | 108 | $35 | $143 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 94 | $72 | $70 |
| Infusion, normal saline solution , 1000 cc | 92 | $2 | $19 |
| Administration of additional new drug or substance into vein using push technique | 90 | $42 | $289 |
| Office visit, established patient, complex (40-54 min) | 84 | $128 | $496 |
| New patient office visit (45-59 min) | 76 | $120 | $565 |
| Ct scan of chest with contrast | 73 | $47 | $821 |
| Unclassified drugs | 72 | $1 | $8 |
| CT scan of abdomen and pelvis with contrast | 59 | $169 | $1,067 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 49 | $15 | $94 |
| Application of on-body injector for under skin injection | 47 | $14 | $96 |
| Irrigation of implanted venous access drug delivery device | 43 | $18 | $114 |
| CT scan of chest, without contrast | 39 | $37 | $691 |
| Ct scan of abdomen and pelvis without contrast | 34 | $76 | $560 |
| Drawing of blood for a medical problem | 30 | $67 | $264 |
| New patient office visit, complex (60-74 min) | 22 | $160 | $709 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.8% high complexity
65.1% medium
6.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$184,926
Total received (2018-2024)
Avg $26,418/year across 7 years
Top 3% in TX for hematology & oncology
57
Companies
474
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$117,963 (63.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$63,756 (34.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,588 (1.4%)
Other
Charitable contributions, space rental, and other categories
$619 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$19,791
2023$29,163
2022$42,683
2021$37,726
2020$30,644
2019$11,875
2018$13,043
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$42,533
AstraZeneca Pharmaceuticals LP
$36,610
Dova Pharmaceuticals
$27,235
Incyte Corporation
$10,824
Genentech USA, Inc.
$9,846
PFIZER INC.
$8,860
Takeda Pharmaceuticals U.S.A., Inc.
$5,289
Pharmacyclics LLC, An AbbVie Company
$4,923
Merck Sharp & Dohme LLC
$4,066
Pharmacosmos Therapeutics Inc.
$3,983
Gilead Sciences, Inc.
$3,667
Bayer Healthcare Pharmaceuticals Inc.
$3,666
GlaxoSmithKline, LLC.
$2,783
BeiGene USA, Inc.
$2,537
Daiichi Sankyo Inc.
$2,526
Athenex Pharmaceutical Division, LLC
$2,075
Seagen Inc.
$1,635
Mirati Therapeutics, Inc.
$1,488
Blueprint Medicines Corporation
$1,199
Astellas Pharma US Inc
$924
Adaptive Biotechnologies Corporation
$828
Seattle Genetics, Inc.
$800
Novocure Inc.
$786
Lilly USA, LLC
$488
BeiGene, Ltd.
$450
Novartis Pharmaceuticals Corporation
$405
Deciphera Pharmaceuticals Inc.
$400
Amgen Inc.
$394
SOBI, INC
$377
Becton, Dickinson and Company
$367
E.R. Squibb & Sons, L.L.C.
$331
NOVARTIS PHARMACEUTICALS CORPORATION
$299
COMSORT, Inc
$250
Novocure GmbH
$200
Covis Pharma GmBH
$200
Rigel Pharmaceuticals, Inc.
$193
ABBVIE INC.
$170
Regeneron Healthcare Solutions, Inc.
$161
Janssen Scientific Affairs, LLC
$119
Alexion Pharmaceuticals, Inc.
$110
Tempus AI, Inc
$100
Cardinal Health 110 LLC
$100
Bayer HealthCare Pharmaceuticals Inc.
$95
TESARO, Inc.
$81
EMD Serono, Inc.
$66
Janssen Biotech, Inc.
$60
JAZZ PHARMACEUTICALS INC.
$59
PharmaEssentia USA Corporation
$56
ARRAY BIOPHARMA INC
$53
AVEO Pharmaceuticals, Inc.
$43
Exelixis Inc.
$42
Eisai Inc.
$39
Ipsen Biopharmaceuticals, Inc
$36
GENZYME CORPORATION
$30
Pharmacyclics LLC, an AbbVie Company
$27
MorphoSys, US Inc.
$24
Kite Pharma, Inc.
$19
Top 3 companies account for 57.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · Aliqopa · Aranesp · BAVENCIO · BESREMI · BRAC CDx · BRAFTOVI · BRUKINSA · CALQUENCE · COLARIS AP · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · ENHERTU · EPKINLY · EndoPredict · FOTIVDA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INLYTA · Imbruvica · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · MVASI · MYCHOICE CDX · MYLOTARG · MYRISK · NINLARO · Neulasta · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · Oncology · Onivyde · Oral Paclitaxel · PADCEV · PEMAZYRE · PIQRAY · PRECISETUMOR · Padcev · PreciseTumor · QINLOCK · Rezlidhia · SOLIRIS · SOMATULINE DEPOT · Stivarga · TECENTRIQ · Tavalisse · Tecentriq · Tecentriq Hybreza · VERZENIO · VONJO · Vectibix · XALKORI · XGEVA · XOSPATA · XT CDX · Xospata · Xtandi · YERVOY · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for hematology & oncology in TX.
Equivalent to $192 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
1
Per 100K population
1.7
County median income
$58,846
Nearest hospital
PALESTINE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dalal is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (consulting-driven, top 3%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dalal experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dalal performed 26,520 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dalal receive payments from pharmaceutical companies?
Yes. Dr. Dalal received a total of $184,926 from 57 companies across 474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dalal's costs compare to other hematology & oncologys in Palestine?
Dr. Dalal's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dalal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Palestine
Browse hematology & oncologys in Palestine ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Dova Pharmaceuticals Payments to Doctors
See all physicians who received payments from Dova Pharmaceuticals.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology